Article Text

Download PDFPDF
Original article
De novo SCAMP5 mutation causes a neurodevelopmental disorder with autistic features and seizures
  1. Laurence Hubert1,
  2. Magda Cannata Serio1,
  3. Laure Villoing-Gaudé1,
  4. Nathalie Boddaert2,
  5. Anna Kaminska3,
  6. Marlène Rio2,
  7. Stanislas Lyonnet1,
  8. Arnold Munnich1,
  9. Karine Poirier1,
  10. Matias Simons1,
  11. Claude Besmond1
  1. 1INSERM UMR1163, Institut IMAGINE, Paris, France
  2. 2IHU Necker Enfants Malades - IMAGINE, Paris, France
  3. 3Clinical Neurophysiology, Hôpital universitaire Necker-Enfants malades, Paris, France
  1. Correspondence to Dr Claude Besmond, INSERM U1163, Institut IMAGINE, Paris 75015, France; claude.besmond{at}inserm.fr; Dr Matias Simons, INSERM UMR1163, Laboratory of Epithelial Biology and Disease, Imagine Institute, Paris, France; matias.simons{at}institutimagine.org

Abstract

Background Autistic spectrum disorders (ASDs) with developmental delay and seizures are a genetically heterogeneous group of diseases caused by at least 700 different genes. Still, a number of cases remain genetically undiagnosed.

Objective The objective of this study was to identify and characterise pathogenic variants in two individuals from unrelated families, both of whom presented a similar clinical phenotype that included an ASD, intellectual disability (ID) and seizures.

Methods Whole-exome sequencing was used to identify pathogenic variants in the two individuals. Functional studies performed in the Drosophila melanogaster model was used to assess the protein function in vivo.

Results Probands shared a heterozygous de novo secretory carrier membrane protein (SCAMP5) variant (NM_001178111.1:c.538G>T) resulting in a p.Gly180Trp missense variant. SCAMP5 belongs to a family of tetraspanin membrane proteins found in secretory and endocytic compartments of neuronal synapses. In the fly SCAMP orthologue, the p.Gly302Trp genotype corresponds to human p.Gly180Trp. Western blot analysis of proteins overexpressed in the Drosophila fat body showed strongly reduced levels of the SCAMP p.Gly302Trp protein compared with the wild-type protein, indicating that the mutant either reduced expression or increased turnover of the protein. The expression of the fly homologue of the human SCAMP5 p.Gly180Trp mutation caused similar eye and neuronal phenotypes as the expression of SCAMP RNAi, suggesting a dominant-negative effect.

Conclusion Our study identifies SCAMP5 deficiency as a cause for ASD and ID and underscores the importance of synaptic vesicular trafficking in neurodevelopmental disorders.

  • clinical genetics
  • neurology
View Full Text

Statistics from Altmetric.com

Footnotes

  • LH, MCS and LV-G contributed equally.

  • MS and CB contributed equally.

  • Correction notice This article has been corrected since it was published Online First. Matias Simon is now correctly listed as corresponding author, together with Claude Besmond.

  • Contributors KP and CB designed the study, analysed the exomes data and wrote the manuscript. LH performed the genetics experiments. LVG, MCS and MS designed and performed the Drosophila experiments. LVG, MCS and MS contributed to figure preparation and manuscript writing. NB performed and reviewed the MRI data. AK performed the EEG examinations. MR, SL and AM were responsible for clinical examinations and included the patients in the study.

  • Funding This work was funded by a grant from the "Fondation Maladies Rares, Paris, France" to CB and by the ATIP-Avenir program, the Fondation Bettencourt-Schueller (Liliane Bettencourt Chair of Developmental Biology) as well as State funding by the Agence Nationale de la Recherche (ANR) under the "Investissements d’avenir” program (ANR-10-IAHU-01) and the NEPHROFLY (ANR-14-ACHN-0013) grant to MS.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.